526 related articles for article (PubMed ID: 28950840)
1. Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report.
Higashi S; Matsunoshita N; Otani M; Tokuhiro E; Nozu K; Ito S
BMC Nephrol; 2017 Sep; 18(1):300. PubMed ID: 28950840
[TBL] [Abstract][Full Text] [Related]
2. CTNS mRNA molecular analysis revealed a novel mutation in a child with infantile nephropathic cystinosis: a case report.
Papizh S; Serzhanova V; Filatova A; Skoblov M; Tabakov V; van den Heuvel L; Levtchenko E; Prikhodina L
BMC Nephrol; 2019 Oct; 20(1):400. PubMed ID: 31672123
[TBL] [Abstract][Full Text] [Related]
3. Nephropathic cystinosis presenting with uveitis: Report of a "Can't See, Can't Pee" situation.
Matthai SM; Jacob S; Bindra MS; David VG; Varughese S
Indian J Pathol Microbiol; 2019; 62(3):457-460. PubMed ID: 31361240
[TBL] [Abstract][Full Text] [Related]
4. Nephropathic cystinosis in children: An overlooked disease.
Soliman NA; El-Baroudy R; Rizk A; Bazaraa H; Younan A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):436-42. PubMed ID: 19414947
[TBL] [Abstract][Full Text] [Related]
5. Nephropathic cystinosis: an update on genetic conditioning.
Topaloglu R
Pediatr Nephrol; 2021 Jun; 36(6):1347-1352. PubMed ID: 32564281
[TBL] [Abstract][Full Text] [Related]
6. Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping.
Servais A; Morinière V; Grünfeld JP; Noël LH; Goujon JM; Chadefaux-Vekemans B; Antignac C
Clin J Am Soc Nephrol; 2008 Jan; 3(1):27-35. PubMed ID: 18178779
[TBL] [Abstract][Full Text] [Related]
7. [Cystinosis : Diagnosis, cystine-depleting therapy, and transition].
Kaufeld J; Weber LT; Kurschat C; Canaan-Kuehl S; Brand E; Oh J; Pape L
Internist (Berl); 2018 Aug; 59(8):861-867. PubMed ID: 29671012
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients.
Bouazza N; Tréluyer JM; Ottolenghi C; Urien S; Deschenes G; Ricquier D; Niaudet P; Chadefaux-Vekemans B
Orphanet J Rare Dis; 2011 Dec; 6():86. PubMed ID: 22195601
[TBL] [Abstract][Full Text] [Related]
9. Cystinosin-deficient rats recapitulate the phenotype of nephropathic cystinosis.
Hollywood JA; Kallingappa PK; Cheung PY; Martis RM; Sreebhavan S; 'Atiola RD; Chatterjee A; Buckels EJ; Matthews BG; Lewis PM; Davidson AJ
Am J Physiol Renal Physiol; 2022 Aug; 323(2):F156-F170. PubMed ID: 35695380
[TBL] [Abstract][Full Text] [Related]
10. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
Nesterova G; Williams C; Bernardini I; Gahl WA
Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
[TBL] [Abstract][Full Text] [Related]
11. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
Brodin-Sartorius A; Tête MJ; Niaudet P; Antignac C; Guest G; Ottolenghi C; Charbit M; Moyse D; Legendre C; Lesavre P; Cochat P; Servais A
Kidney Int; 2012 Jan; 81(2):179-89. PubMed ID: 21900880
[TBL] [Abstract][Full Text] [Related]
12. Chitotriosidase plasma activity in nephropathic cystinosis.
Xaidara A; Karavitakis EM; Kosma K; Emma F; Dimitriou E; Michelakakis H
J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S157-9. PubMed ID: 19455402
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis.
Hohenfellner K; Nießl C; Haffner D; Oh J; Okorn C; Palm K; Schlingmann KP; Wygoda S; Gahl WA
Mol Genet Metab; 2022 Aug; 136(4):282-288. PubMed ID: 35843134
[TBL] [Abstract][Full Text] [Related]
14. [Nephropathic cystinosis: report of 2 cases and review of the literature].
Knoepfelmacher M; Rocha R; Salgado LR; Semer M; Voss D; Wajchenberg BL; Liberman B
Rev Assoc Med Bras (1992); 1994; 40(1):43-6. PubMed ID: 8061694
[TBL] [Abstract][Full Text] [Related]
15. Nephropathic Cystinosis: Symptoms, Treatment, and Perspectives of a Systemic Disease.
Bäumner S; Weber LT
Front Pediatr; 2018; 6():58. PubMed ID: 29594088
[TBL] [Abstract][Full Text] [Related]
16. More than tubular dysfunction: cystinosis and kidney outcomes.
Atmis B; K Bayazit A; Cevizli D; Kor D; Fidan HB; Bisgin A; Kilavuz S; Unal I; Erdogan KE; Melek E; Gonlusen G; Anarat A; Onenli Mungan N
J Nephrol; 2022 Apr; 35(3):831-840. PubMed ID: 34097292
[TBL] [Abstract][Full Text] [Related]
17. Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study.
Veys K; Zadora W; Hohenfellner K; Bockenhauer D; Janssen MCH; Niaudet P; Servais A; Topaloglu R; Besouw M; Novo R; Haffner D; Kanzelmeyer N; Pape L; Wühl E; Harms E; Awan A; Sikora P; Ariceta G; van den Heuvel B; Levtchenko E
J Inherit Metab Dis; 2023 Jan; 46(1):43-54. PubMed ID: 36117148
[TBL] [Abstract][Full Text] [Related]
18. Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.
Ahlenstiel-Grunow T; Kanzelmeyer NK; Froede K; Kreuzer M; Drube J; Lerch C; Pape L
Pediatr Nephrol; 2017 Jan; 32(1):91-97. PubMed ID: 27350621
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term cysteamine treatment in patients with cystinosis.
Ariceta G; Giordano V; Santos F
Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
